%0 Journal Article
%T Experience of Using the Recombinant Human Superoxide Dismutase Drug in Neurological and Ophthalmological Practice
%A Elena E. Dubinina
%A Irina V. Churilova
%A Liudmila V. Lipatova
%A Liudmila V. Zhuravleva
%J Open Journal of Medicinal Chemistry
%P 70-78
%@ 2164-313X
%D 2014
%I Scientific Research Publishing
%R 10.4236/ojmc.2014.42005
%X <div align=\"justify\">
	Recsod<sup>?</sup> has been used for treating epilepsy and ophthalmological disease. Oxidative stress has been demonstrated to be a pathogenic chain of these diseases. Parameters of pro- and antioxidant systems were studied in all the patients treated. Recsod<sup>?</sup> drug was shown to produce positive effect in all the patients. Improvement of patients¡¯ clinical condition correlated with an increase in antioxidant activities. Antioxidants, in particular, the recombinant human SOD drug, proved to be effective in treatment of some neurological and ophthalmological diseases.
</div>
%K Superoxide Dismutase
%K Oxidative Stress
%K Reactive Oxygen Species
%K Epilepsy
%K Age-Related Macular Degeneration
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=47132